Increases in plasma corin levels following experimental myocardial infarction reflect the severity of ischemic injury

Dong Wang, Inna P. Gladysheva, Ryan D. Sullivan, Tai-Hwang Fan, Radhika M. Mehta, Ranjana Tripathi, Yao Sun, Guy L. Reed

Research output: Contribution to journalArticle

Abstract

Following acute myocardial infarction, clinical studies show alterations in the blood levels of corin, a cardiac-selective activator of the natriuretic peptides pro-atrial natriuretic peptide (pro-ANP) and pro-B-type natriuretic peptide (pro-BNP). However, the temporal changes in circulating and cardiac corin levels and their relationships to the severity of myocardial infarction have not been studied. The main objective of this study was to examine the relationship between cardiac and circulating corin levels and their association with cardiac systolic function and infarct size during the early phase of acute myocardial infarction (<72 h) in a translationally relevant induced coronary ligation mouse model. This acute phase timeline was chosen to correlate with the clinical practice within which blood samples are collected from myocardial infarction patients. Heart and plasma samples were examined at 3, 24, and 72 hours post acute myocardial infarction. Plasma corin levels were examined by enzyme-linked immunosorbent assay, transcripts of cardiac corin, pro-ANP and pro-BNP by quantitative real-time polymerase chain reaction, cardiac corin expression by immunohistology, infarct size by histology and heart function by echocardiography. Plasma corin levels were significantly increased at 3 (P<0.05), 24 (P<0.001), and 72 hours (P<0.01) post-acute myocardial infarction. In contrast, cardiac corin transcript levels dropped by 5% (P>0.05), 69% (P<0.001) and 65% (P<0.001) and immunoreactive cardiac corin protein levels dropped by 30% (P<0.05), 76% (P<0.001) and 75% (P<0.001), while cardiac pro-ANP and pro-BNP transcript levels showed an opposite pattern. Plasma corin levels were negatively correlated with immunoreactive cardiac corin (P<0.01), ejection fraction (P<0.05) and fractional shortening (P<0.05), but positively correlated with infarct size (P<0.01). In conclusion, acute myocardial infarction induces rapid increases in plasma corin and decreases in cardiac corin levels. In the early phase of acute myocardial infarction, plasma corin levels are inversely correlated with heart function and may reflect the severity of myocardial damage.

Original languageEnglish (US)
Article numbere0202571
JournalPloS one
Volume13
Issue number9
DOIs
StatePublished - Sep 1 2018

Fingerprint

myocardial infarction
natriuretic peptides
Brain Natriuretic Peptide
Myocardial Infarction
Atrial Natriuretic Factor
Plasmas
Wounds and Injuries
atrial natriuretic peptide
infarction
Natriuretic Peptides
Blood
shortenings
clinical trials
heart
Proteins
blood
proteins
peptide B

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Wang, D., Gladysheva, I. P., Sullivan, R. D., Fan, T-H., Mehta, R. M., Tripathi, R., ... Reed, G. L. (2018). Increases in plasma corin levels following experimental myocardial infarction reflect the severity of ischemic injury. PloS one, 13(9), [e0202571]. https://doi.org/10.1371/journal.pone.0202571

Increases in plasma corin levels following experimental myocardial infarction reflect the severity of ischemic injury. / Wang, Dong; Gladysheva, Inna P.; Sullivan, Ryan D.; Fan, Tai-Hwang; Mehta, Radhika M.; Tripathi, Ranjana; Sun, Yao; Reed, Guy L.

In: PloS one, Vol. 13, No. 9, e0202571, 01.09.2018.

Research output: Contribution to journalArticle

Wang, Dong ; Gladysheva, Inna P. ; Sullivan, Ryan D. ; Fan, Tai-Hwang ; Mehta, Radhika M. ; Tripathi, Ranjana ; Sun, Yao ; Reed, Guy L. / Increases in plasma corin levels following experimental myocardial infarction reflect the severity of ischemic injury. In: PloS one. 2018 ; Vol. 13, No. 9.
@article{c748cacdb0a7431e837cfd95462f51f0,
title = "Increases in plasma corin levels following experimental myocardial infarction reflect the severity of ischemic injury",
abstract = "Following acute myocardial infarction, clinical studies show alterations in the blood levels of corin, a cardiac-selective activator of the natriuretic peptides pro-atrial natriuretic peptide (pro-ANP) and pro-B-type natriuretic peptide (pro-BNP). However, the temporal changes in circulating and cardiac corin levels and their relationships to the severity of myocardial infarction have not been studied. The main objective of this study was to examine the relationship between cardiac and circulating corin levels and their association with cardiac systolic function and infarct size during the early phase of acute myocardial infarction (<72 h) in a translationally relevant induced coronary ligation mouse model. This acute phase timeline was chosen to correlate with the clinical practice within which blood samples are collected from myocardial infarction patients. Heart and plasma samples were examined at 3, 24, and 72 hours post acute myocardial infarction. Plasma corin levels were examined by enzyme-linked immunosorbent assay, transcripts of cardiac corin, pro-ANP and pro-BNP by quantitative real-time polymerase chain reaction, cardiac corin expression by immunohistology, infarct size by histology and heart function by echocardiography. Plasma corin levels were significantly increased at 3 (P<0.05), 24 (P<0.001), and 72 hours (P<0.01) post-acute myocardial infarction. In contrast, cardiac corin transcript levels dropped by 5{\%} (P>0.05), 69{\%} (P<0.001) and 65{\%} (P<0.001) and immunoreactive cardiac corin protein levels dropped by 30{\%} (P<0.05), 76{\%} (P<0.001) and 75{\%} (P<0.001), while cardiac pro-ANP and pro-BNP transcript levels showed an opposite pattern. Plasma corin levels were negatively correlated with immunoreactive cardiac corin (P<0.01), ejection fraction (P<0.05) and fractional shortening (P<0.05), but positively correlated with infarct size (P<0.01). In conclusion, acute myocardial infarction induces rapid increases in plasma corin and decreases in cardiac corin levels. In the early phase of acute myocardial infarction, plasma corin levels are inversely correlated with heart function and may reflect the severity of myocardial damage.",
author = "Dong Wang and Gladysheva, {Inna P.} and Sullivan, {Ryan D.} and Tai-Hwang Fan and Mehta, {Radhika M.} and Ranjana Tripathi and Yao Sun and Reed, {Guy L.}",
year = "2018",
month = "9",
day = "1",
doi = "10.1371/journal.pone.0202571",
language = "English (US)",
volume = "13",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - Increases in plasma corin levels following experimental myocardial infarction reflect the severity of ischemic injury

AU - Wang, Dong

AU - Gladysheva, Inna P.

AU - Sullivan, Ryan D.

AU - Fan, Tai-Hwang

AU - Mehta, Radhika M.

AU - Tripathi, Ranjana

AU - Sun, Yao

AU - Reed, Guy L.

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Following acute myocardial infarction, clinical studies show alterations in the blood levels of corin, a cardiac-selective activator of the natriuretic peptides pro-atrial natriuretic peptide (pro-ANP) and pro-B-type natriuretic peptide (pro-BNP). However, the temporal changes in circulating and cardiac corin levels and their relationships to the severity of myocardial infarction have not been studied. The main objective of this study was to examine the relationship between cardiac and circulating corin levels and their association with cardiac systolic function and infarct size during the early phase of acute myocardial infarction (<72 h) in a translationally relevant induced coronary ligation mouse model. This acute phase timeline was chosen to correlate with the clinical practice within which blood samples are collected from myocardial infarction patients. Heart and plasma samples were examined at 3, 24, and 72 hours post acute myocardial infarction. Plasma corin levels were examined by enzyme-linked immunosorbent assay, transcripts of cardiac corin, pro-ANP and pro-BNP by quantitative real-time polymerase chain reaction, cardiac corin expression by immunohistology, infarct size by histology and heart function by echocardiography. Plasma corin levels were significantly increased at 3 (P<0.05), 24 (P<0.001), and 72 hours (P<0.01) post-acute myocardial infarction. In contrast, cardiac corin transcript levels dropped by 5% (P>0.05), 69% (P<0.001) and 65% (P<0.001) and immunoreactive cardiac corin protein levels dropped by 30% (P<0.05), 76% (P<0.001) and 75% (P<0.001), while cardiac pro-ANP and pro-BNP transcript levels showed an opposite pattern. Plasma corin levels were negatively correlated with immunoreactive cardiac corin (P<0.01), ejection fraction (P<0.05) and fractional shortening (P<0.05), but positively correlated with infarct size (P<0.01). In conclusion, acute myocardial infarction induces rapid increases in plasma corin and decreases in cardiac corin levels. In the early phase of acute myocardial infarction, plasma corin levels are inversely correlated with heart function and may reflect the severity of myocardial damage.

AB - Following acute myocardial infarction, clinical studies show alterations in the blood levels of corin, a cardiac-selective activator of the natriuretic peptides pro-atrial natriuretic peptide (pro-ANP) and pro-B-type natriuretic peptide (pro-BNP). However, the temporal changes in circulating and cardiac corin levels and their relationships to the severity of myocardial infarction have not been studied. The main objective of this study was to examine the relationship between cardiac and circulating corin levels and their association with cardiac systolic function and infarct size during the early phase of acute myocardial infarction (<72 h) in a translationally relevant induced coronary ligation mouse model. This acute phase timeline was chosen to correlate with the clinical practice within which blood samples are collected from myocardial infarction patients. Heart and plasma samples were examined at 3, 24, and 72 hours post acute myocardial infarction. Plasma corin levels were examined by enzyme-linked immunosorbent assay, transcripts of cardiac corin, pro-ANP and pro-BNP by quantitative real-time polymerase chain reaction, cardiac corin expression by immunohistology, infarct size by histology and heart function by echocardiography. Plasma corin levels were significantly increased at 3 (P<0.05), 24 (P<0.001), and 72 hours (P<0.01) post-acute myocardial infarction. In contrast, cardiac corin transcript levels dropped by 5% (P>0.05), 69% (P<0.001) and 65% (P<0.001) and immunoreactive cardiac corin protein levels dropped by 30% (P<0.05), 76% (P<0.001) and 75% (P<0.001), while cardiac pro-ANP and pro-BNP transcript levels showed an opposite pattern. Plasma corin levels were negatively correlated with immunoreactive cardiac corin (P<0.01), ejection fraction (P<0.05) and fractional shortening (P<0.05), but positively correlated with infarct size (P<0.01). In conclusion, acute myocardial infarction induces rapid increases in plasma corin and decreases in cardiac corin levels. In the early phase of acute myocardial infarction, plasma corin levels are inversely correlated with heart function and may reflect the severity of myocardial damage.

UR - http://www.scopus.com/inward/record.url?scp=85053268180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053268180&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0202571

DO - 10.1371/journal.pone.0202571

M3 - Article

VL - 13

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e0202571

ER -